In January 2026, MIT Technology Review named AI-driven embryo scoring one of its 10 Breakthrough Technologies of the year. In March, researchers at the Carlos Simon Foundation in Valencia, Spain, kept a donated human uterus alive outside the body for 24 hours—the first time this has ever been accomplished. And in labs across the world, robots are now performing some of the most delicate procedures in IVF, from injecting sperm into eggs to handling embryos with precision no human hand can match.
If you’re trying to conceive in 2026, most of this technology won’t directly affect your treatment cycle. But it’s reshaping the landscape of what’s possible—and some of it is closer to clinical practice than you might think.
AI Embryo Scoring: Already in Clinics
This is the furthest along and the most immediately relevant. Traditionally, embryologists select which embryo to transfer by visually grading its appearance under a microscope—essentially choosing the one that “looks best.” It’s a skilled judgment call, but it’s inherently subjective. Two experienced embryologists can disagree about the same embryo.
AI embryo scoring systems analyze time-lapse images of developing embryos and assign a score based on patterns that correlate with implantation success. These systems have been trained on hundreds of thousands of embryo images and their outcomes, giving them a data set no individual embryologist could accumulate in a lifetime.
Multiple fertility networks—including RMA, CCRM, and clinics using the iDAScore and ERICA platforms—are now incorporating AI scoring into their clinical workflows. The technology doesn’t replace the embryologist; it provides an additional data point to inform the selection decision.
Robot-Assisted IVF: From Lab Curiosity to Clinical Trials
The most technically demanding step in IVF is ICSI (intracytoplasmic sperm injection)—the procedure where a single sperm is injected into an egg using a microscopic needle. It requires steady hands, specialized training, and years of practice. Human error, however small, can damage eggs.
Several research teams are developing robotic systems that can perform ICSI with greater precision and consistency than human operators. The first babies conceived using robot-assisted sperm injection were born in 2023, and the technology has been advancing steadily since. At the Carlos Simon Foundation in Valencia, researchers have built a device that injects embryos into the uterine lining at the press of a button—a robotic approach to embryo transfer, which is currently one of the most operator-dependent steps in IVF.
The promise of robotic IVF is twofold: better outcomes through reduced human error, and lower costs through automation. If robots can reliably perform procedures that currently require a highly trained embryologist, IVF could become less expensive and more widely accessible—particularly in regions where trained embryologists are scarce.
The timeline: Robot-assisted ICSI is in clinical trials now. It is likely to become commercially available at some fertility clinics within the next 3–5 years, initially as a supplement to (not a replacement for) human embryologists.
The Artificial Uterus: Groundbreaking but Distant
In March 2026, the Carlos Simon Foundation achieved something unprecedented: maintaining a donated human uterus outside the body for 24 hours using a perfusion device nicknamed “Mother” (formally PUPER—Preservation of the Uterus in Perfusion). The device pumps warmed, oxygenated, nutrient-rich blood through the organ using a system that mimics heart, lung, and kidney functions.
The immediate goal is not to gestate babies outside the body. The research team wants to keep donated uteruses alive long enough to observe a full menstrual cycle, which would allow them to study how embryos implant into the uterine lining—one of the least understood and most failure-prone steps in IVF. Understanding implantation at this level could lead to significant improvements in transfer success rates.
The longer-term vision—full ectogenesis, or gestating a human fetus entirely outside a body—remains firmly in the realm of speculative science. The complex interplay of placental function, immune tolerance, hormonal signaling, and sensory inputs required for normal fetal development far exceeds what any current technology can replicate. No human has been gestated outside a body, and that is unlikely to change within the current decade.
The more realistic near-term application is partial ectogenesis for extremely premature infants—artificial womb systems that could support babies born before 24 weeks of gestation, a population with very high mortality rates. Several research teams are working on this application, and it could reach clinical trials within the next 5–10 years.
AI Sperm Selection: Scanning a Million Images Per Hour
Selecting the best sperm for ICSI is one of the most time-intensive tasks in the IVF lab. An embryologist examines sperm under a microscope, evaluating motility and morphology by eye—a process that is inherently limited by human visual processing speed and subjectivity.
AI sperm selection systems can analyze over a million sperm images per hour, identifying subtle quality markers that human eyes may miss. These systems evaluate not just the shape and movement of sperm, but patterns in how they swim, the integrity of their heads, and other micro-features that correlate with fertilization success and embryo quality.
Several clinics are already using AI-assisted sperm selection, and the technology is particularly valuable for patients with severe male factor infertility, where finding the small number of high-quality sperm among millions of abnormal ones is like finding a needle in a haystack. For these patients, AI selection can meaningfully improve the odds that the right sperm reaches the right egg.
The Desktop IVF Lab
One of the most ambitious visions in reproductive technology is the “desktop IVF lab”—a compact, automated system that could perform the core IVF laboratory procedures (egg assessment, sperm selection, ICSI, embryo culture, and grading) in a single device. Multiple startups are working toward versions of this concept, using microfluidics, robotics, and AI to miniaturize and automate what currently requires a full-scale embryology laboratory and a team of specialists.
The potential impact is enormous. A desktop lab could reduce the cost of IVF by eliminating the overhead of a full laboratory facility. It could bring IVF to rural areas, developing countries, and any location where trained embryologists are scarce. And it could standardize quality by removing the variability inherent in human-operated procedures.
The technology is not ready for clinical use, and significant regulatory hurdles remain. But the concept represents the logical endpoint of the automation trend: IVF that is as accessible as any other outpatient medical procedure, available anywhere a physician can operate a device.
Other Technologies to Watch
In vitro gametogenesis (IVG). The creation of eggs and sperm from ordinary skin or blood cells. If successful, IVG would theoretically allow anyone—regardless of age, sex, or reproductive organs—to produce their own genetic offspring. The technology works in mice. In humans, it remains in early-stage research and faces enormous technical and ethical hurdles. A good science book on reproductive technology can help you follow these developments as they evolve.
Non-invasive PGT. Current genetic testing of embryos requires removing cells via biopsy—a technically demanding procedure that carries a small risk of embryo damage. Non-invasive PGT (niPGT) analyzes DNA shed by the embryo into its culture medium, potentially providing genetic information without touching the embryo at all. Early results are promising but not yet reliable enough for clinical use.
AI-optimized stimulation protocols. Machine learning models that analyze a patient’s hormone levels, age, BMI, and ovarian reserve to recommend personalized medication dosing—potentially improving egg yield while reducing the risk of ovarian hyperstimulation. Several startups are developing these tools, and some are already in clinical testing.
What This Means for You Today
If you’re trying to conceive in 2026, the technologies most likely to affect your care right now are AI embryo scoring (available at select clinics) and improved cryopreservation techniques (which have steadily improved frozen embryo transfer outcomes over the past decade). The robot and artificial uterus research is exciting, but it’s years away from your treatment room.
The most impactful thing you can do today is work with a reproductive endocrinologist who stays current with evidence-based advances and incorporates proven technologies into their practice. Today’s IVF—with vitrification, time-lapse monitoring, single embryo transfer protocols, and comprehensive genetic testing—is already dramatically more effective than the IVF of even five years ago.
For a grounded look at what IVF involves right now, see ConceiveGuide’s week-by-week IVF timeline and our guide to IVF success rates by age.
Ready to Take the Next Step?
Whether it’s IUI, IVF, or something in between, understanding your options is the first step.
Explore Your Options →FTC Disclosure: Some links in this article are affiliate links. If you purchase through them, we may earn a small commission at no extra cost to you. This does not influence our recommendations, which are based on evidence and editorial judgment.